Texas Legal professional Basic Ken Paxton sued the makers of Tylenol, Johnson & Johnson and Kenvue, claiming that they deceptively marketed the over-the-counter medicine to pregnant ladies regardless of alleged hyperlinks to autism and different issues.
“Massive Pharma betrayed America by profiting off of ache and pushing tablets whatever the dangers,” Paxton stated in a press release on Tuesday. “These companies lied for many years, knowingly endangering thousands and thousands to line their pockets. … By holding Massive Pharma accountable for poisoning our folks, we’ll assist Make America Wholesome Once more.”
That is the primary lawsuit from a state authorities since President Donald Trump claimed final month that Tylenol use throughout being pregnant is linked to an elevated threat of autism, regardless of restricted proof to recommend an affiliation.
Tylenol packages and caplets are displayed, in Los Angeles, September 22, 2025.
Valerie Macon/AFP through Getty Pictures
Johnson & Johnson offered the drug for many years and its shopper well being division spinoff, Kenvue Inc., has been promoting the drug since 2023.
In a press release, Kenvue pushed again on the legal professional normal’s claims, saying it’s “deeply involved by the perpetuation of misinformation on the security of acetaminophen and the potential affect that might have on the well being of American ladies and youngsters.”
“Acetaminophen is the most secure ache reliever possibility for pregnant ladies as wanted all through their complete being pregnant. With out it, ladies face harmful selections: endure by means of circumstances like fever which are doubtlessly dangerous to each mother and child or use riskier alternate options. Excessive fevers and ache are well known as potential dangers to a being pregnant if left untreated
,” the assertion learn. “We’ll defend ourselves in opposition to these baseless claims and reply per the authorized course of. We stand firmly with the worldwide medical neighborhood that acknowledges the security of acetaminophen and consider we’ll proceed to achieve success in litigation as these claims lack authorized benefit and scientific assist.”This can be a creating story. Please verify again for updates.
